What Is the Next Beijing Sun Novo Pharmaceutical Research Earnings Date?

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Industry

Biotechnology & Medical Research

Sector

Healthcare

Employees

1185

Market

China

Compare 688621 to Peers and Sector

Metrics to compare	688621	Peers Peers - average of corresponding metrics from companies closely matching 688621: 300404, 300347, 300759, 603259, 688202	Sector Sector - Average of metrics from a broad group of related Healthcare sector companies	Relationship Relationship688621PeersSector
P/E Ratio	21.7x	26.6x	−0.7x
PEG Ratio	1.95	−1.13	0.00
Price/Book	4.3x	2.8x	2.6x
Price / LTM Sales	4.2x	4.5x	3.2x
Upside (Analyst Target)	-	14.0%	44.1%
Fair Value Upside	Unlock	10.0%	8.2%	Unlock

Analysts' Recommendations

2 Buy

0 Hold

0 Sell

Ratings:

0 analysts

Overall Consensus

Strong Buy

Analysts 12-Month Price Target:

Average 0.00

More details

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS 1.97

Dividend Yield

0.40%

Industry Median 0.62%

Annualized payout

0.1650

Paid annually

5-Years Growth

Growth Streak

Unlock

More details

688621 Income Statement

FAQ

What Is the Beijing Sun Novo Pharmaceutical Research (688621) Stock Price Today?

The Beijing Sun Novo Pharmaceutical Research stock price today is 42.96

What Stock Exchange Does Beijing Sun Novo Pharmaceutical Research Trade On?

Beijing Sun Novo Pharmaceutical Research is listed and trades on the Shanghai stock exchange.

What Is the Stock Symbol for Beijing Sun Novo Pharmaceutical Research?

The stock symbol for Beijing Sun Novo Pharmaceutical Research is "688621."

Does Beijing Sun Novo Pharmaceutical Research Pay Dividends? What’s The Current Dividend Yield?

The Beijing Sun Novo Pharmaceutical Research dividend yield is 0.38%.

What Is the Beijing Sun Novo Pharmaceutical Research Market Cap?

As of today, Beijing Sun Novo Pharmaceutical Research market cap is 4.61B.

What is Beijing Sun Novo Pharmaceutical Research Earnings Per Share?

The Beijing Sun Novo Pharmaceutical Research EPS is 1.97.

From a Technical Analysis Perspective, Is 688621 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

S&P/TSX

25,761.29

+81.25

+0.32%

S&P/TSX 60

1,546.03

+6.98

+0.45%

US 30

44,791.30

+25.6

+0.06%

US 500

6,093.50

+18.4

+0.30%

S&P 500 VIX

13.01

-0.53

-3.91%

DAX

20,403.65

+36.93

+0.18%

Dollar Index

106.022

+0.321

+0.30%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	45.75	-1.91%	7.59M
Great-West Lifeco	48.89	+0.04%	5.64M
Suncor Energy	54.18	-1.40%	3.54M
Toronto Dominion Bank	73.50	-0.70%	3.25M
Bank of Nova Scotia	79.53	+1.58%	1.70M
Bank of Montreal	145.52	+4.14%	1.46M
National Bank of Canada	133.48	-1.26%	962.14K

Name	Last	Chg. %	Vol.
Canada Carbon Inc.	0.03	+150.00%	1.00
Backstageplay	0.0800	+128.57%	5.00K
E2Gold	0.01	+100.00%	60.00K
Romios Gold Resources	0.015	+50.00%	3.00K
Arctic Star Exploration	0.02	+50.00%	1.00
Ostrom Climate Solutions	0.0700	+40.00%	27.00K
Canadian Silver Hunter	0.0200	+33.33%	2.00K

Name	Last	Chg. %	Vol.
TVI Pacific	0.01	-50.00%	700.00K
Silver Spruce Resources	0.0050	-50.00%	600.00K
Marksmen Energy Inc	0.0050	-50.00%	665.99K
Katipult	0.0050	-50.00%	70.00K
Waverley Pharma	0.0100	-50.00%	12.00K
genifi inc	0.0100	-33.33%	6.00K
Vendetta Mining	0.0100	-33.33%	2.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	73.54	-0.65%	3.14M
Bank of Montreal	145.52	+4.14%	1.46M
Canadian Imperial Bank	93.39	-0.16%	1.09M
Hut 8	44.520	+14.71%	1.47M
Air Canada	25.89	+0.90%	1.12M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa Aaaa Aaaaaa	62.13	+33.97%	83.24
Aaaaaaaaaaaaaaaaa	43.94	+32.56%	58.25
Aaaaa	39.33	+31.78%	51.83
Aaaaaaaaa Aaaaaaa	39.71	+27.82%	50.76
A Aa A	74.37	+27.65%	94.93
Aa Aaaa Aaaaaaaaa	73.50	+23.14%	90.51
Aaaaaaaaaaaa Aaaa	133.49	+22.35%	163.33

Name	Last	Upside	Fair Value
Aaaaaaaa Aaaa Aaaaaa	62.13	+33.97%	83.24
Aaaaaaaaaaaaaaaaa	43.94	+32.56%	58.25
Aaaaa	39.33	+31.78%	51.83
Aaaaaaaaa Aaaaaaa	39.71	+27.82%	50.76
A Aa A	74.37	+27.65%	94.93
Aa Aaaa Aaaaaaaaa	73.50	+23.14%	90.51
Aaaaaaaaaaaa Aaaa	133.49	+22.35%	163.33

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Beijing Sun Novo Pharmaceutical Research Co Ltd Company Profile